Symbols
“Do Not Use” list of abbreviations
3.3 Documentation and Informatics
17-beta-estradiol
37.2 Feminizing Hormonal Therapy
5-alpha-reductase inhibitors
36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors,
36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
5-Fluorouracil
8.2 Chemotherapeutic Drugs
A
A (Retinol and beta carotene)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Abilify
13.2 Antipsychotics
abortifacients
36.3 Uterine Motility Drugs and Lactation Considerations
Abortive therapy
12.2 Migraine Headaches and Migraine Headache Drugs
absence seizures
12.1 Epilepsy and Anticonvulsant Drugs
Absorption
2.2 Pharmacokinetics and Pharmacodynamics,
29.1 Introduction to the Gastrointestinal System and Oral Cavity
abuse deterrence
15.2 Opioid Use Disorder Drugs
accommodation
38.1 Introduction to the Eyes
ACE inhibitor
13.2 Antipsychotics
Acebutolol
17.1 Introduction to Dysrhythmias
Acetaminophen
14.2 Nonopioid Analgesics
Acetylcholine
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
Introduction,
25.1 Adrenergics and Anticholinergics
acetylcholinesterase inhibitor
13.4 Anxiolytics and Sedative-Hypnotics
Acetylcysteine
24.3 Expectorants and Mucolytics
ACh
Introduction
Aciphex
10.4 Alzheimer’s Drugs
Acitretin
40.3 Psoriatic Drugs
Acne vulgaris
40.2 Acne Drugs
Acnecycline
40.2 Acne Drugs
acquired immunity
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
acquired immunodeficiency syndrome (AIDS)
7.3 Introduction to HIV, AIDS, and Antiretrovirals
acromegaly
26.2 Growth Hormones and Suppressants
action potential
16.3 Conduction of Electrical Impulses
Activase
20.4 Thrombolytics
Activated clotting time (ACT)
20.2 Anticoagulants
Active immunity
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
active transport
4.1 What Is Homeostasis?
Actonel
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
acute angle-closure (narrow-angle) glaucoma
38.4 Antiglaucoma Drugs
acute kidney injury (AKI)
34.1 Introduction to Diuretics
acute myocardial infarction
22.1 Introduction to Cardiac Emergencies and Shock
Acute pain
14.1 Introduction to Pain
Acyclovir
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Adalimumab
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
40.3 Psoriatic Drugs
Adapalene
40.2 Acne Drugs
adaptive immune system
6.1 Introduction to Immunity
adaptive immunity
7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
Addison’s disease
26.4 Glucocorticoids and Mineralocorticoids
Adenocarcinomas
8.1 Introduction to Cancer and Phases of Cancer Therapy
Adenocard
17.6 Unclassified Antidysrhythmics
Adenosine
17.1 Introduction to Dysrhythmias,
17.6 Unclassified Antidysrhythmics,
22.2 Cardiac Emergency Drugs
adenosine 5-triphosphate (ATP)
4.3 Maintaining Homeostasis
Adenosine diphosphate
20.1 Introduction to Clotting and Coagulation
Adipex-P
32.2 Anorexiants
Adjuvant therapy
8.2 Chemotherapeutic Drugs
Adlarity
10.4 Alzheimer’s Drugs
adrenal insufficiency
25.2 Corticosteroids
Adrenalin
25.1 Adrenergics and Anticholinergics
adrenaline
22.2 Cardiac Emergency Drugs
Adrenergic
25.1 Adrenergics and Anticholinergics
adrenergic agonist
22.2 Cardiac Emergency Drugs
Adrenocorticotropic hormone (ACTH)
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Adriamycin
8.2 Chemotherapeutic Drugs
adverse drug event
1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice ,
3.2 Drug Errors and Prevention,
3.3 Documentation and Informatics
adverse drug reaction
3.2 Drug Errors and Prevention
adverse effects
1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
Advil
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
14.2 Nonopioid Analgesics
affective
13.1 Antidepressants
affective domain
2.1 Drug Administration and the Nursing Process
African descent
28.1 Introduction to Diabetes
Agency for Healthcare Research and Quality
3.3 Documentation and Informatics
agranulocytosis
31.2 Histamine Blockers and Proton-Pump Inhibitors
Alaska Native
28.1 Introduction to Diabetes
Alcohol
15.3 Alcohol Use Disorder Drugs
Aldactone
18.6 Diuretics,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System,
34.4 Potassium-Sparing Diuretics
aldosterone
18.1 Hypertension and Angina
aldosterone antagonists
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Alendronate
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Aleve
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
14.2 Nonopioid Analgesics
alimentary canal
29.1 Introduction to the Gastrointestinal System and Oral Cavity
Alimta
8.2 Chemotherapeutic Drugs
Alka-Seltzer
31.1 Antacids
Alkyl Sulfonates
8.2 Chemotherapeutic Drugs
Alkylating agents
8.2 Chemotherapeutic Drugs
Alkylating-Like Drugs
8.2 Chemotherapeutic Drugs
allergic reaction
3.2 Drug Errors and Prevention,
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Allopurinol
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
8.1 Introduction to Cancer and Phases of Cancer Therapy
alpha blockers
36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
alpha receptors
9.3 Characteristics of Drugs to Treat Nervous System Disorders
Alpha- and beta-adrenergic agonists
25.1 Adrenergics and Anticholinergics
alpha-1 receptor agonist
22.3 Shock Drugs
alpha-2 adrenergic agonist
13.4 Anxiolytics and Sedative-Hypnotics
alpha-adrenergic blockers
12.2 Migraine Headaches and Migraine Headache Drugs
Alpha-glucosidase inhibitors
28.3 Oral Antidiabetic Drugs
alpha-synuclein
11.1 Introduction to Parkinson’s Disease
Alphagan P
38.4 Antiglaucoma Drugs
Alteplase
20.4 Thrombolytics
Aluminum hydroxide
31.1 Antacids
Alzheimer’s disease (AD)
10.3 Introduction to Alzheimer’s Disease
Amantadine
11.2 Anti-Parkinsonian Drugs
American Academy of Child and Adolescent Psychiatry
13.2 Antipsychotics
American Academy of Ophthalmology
38.1 Introduction to the Eyes
American College of Obstetricians and Gynecologists
36.2 Hormonal, Contraception, and Infertility Drugs
American Geriatrics Society Beers Criteria
11.2 Anti-Parkinsonian Drugs
American Heart Association
18.1 Hypertension and Angina,
21.1 Introduction to Lipoprotein and Apolipoproteins,
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors,
22.1 Introduction to Cardiac Emergencies and Shock,
32.1 Introduction to Weight Management
American Indian
28.1 Introduction to Diabetes
American Lung Association
23.2 Introduction to the Lower Respiratory System
American Nurses Association (ANA)
3.2 Drug Errors and Prevention
American Psychiatric Association
13.1 Antidepressants
Amino acids
32.1 Introduction to Weight Management
aminoglycosides
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
amiodarone
11.2 Anti-Parkinsonian Drugs ,
17.1 Introduction to Dysrhythmias,
17.4 Class III: Potassium Channel Blockers,
22.2 Cardiac Emergency Drugs
Amlodipine
18.5 Calcium Channel Blockers
Amoxicillin-clavulanate
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
39.2 Otic Anti-inflammatories and Anti-infectives
Amphetamine and dextroamphetamine
13.5 CNS Stimulants and Nonstimulants
Amphojel
31.1 Antacids
Amylin Analogs
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
ANA Code of Ethics
3.2 Drug Errors and Prevention
Anabolic steroids
36.6 Androgens, Antiandrogens, and Anabolic Steroids
Anaphylactic shock
22.3 Shock Drugs
Anastrozole
8.3 Hormonal Therapy
Androgens
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus,
36.6 Androgens, Antiandrogens, and Anabolic Steroids
Andropause
36.5 Review of the Male Reproductive System
angioedema
13.4 Anxiolytics and Sedative-Hypnotics,
35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Angiomax
20.2 Anticoagulants
angiotensin I
18.1 Hypertension and Angina
angiotensin II
18.1 Hypertension and Angina
Angiotensin II receptor blockers (ARBs)
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
angiotensin receptor/neprilysin inhibitors (ARNIs)
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Angiotensin-converting enzyme (ACE) inhibitors
18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Anhidrosis
11.2 Anti-Parkinsonian Drugs
Anidulafungin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
39.1 Introduction to the Ears
anions
4.1 What Is Homeostasis?
Anorexiants
32.2 Anorexiants
Antabuse
15.3 Alcohol Use Disorder Drugs
antagonist
2.2 Pharmacokinetics and Pharmacodynamics
anterograde amnesia
13.4 Anxiolytics and Sedative-Hypnotics
anthelminthic agents
7.6 Antiparasitic and Anthelminthic Drugs
Anthracyclines/Antitumor Antibiotics
8.2 Chemotherapeutic Drugs
Anti-factor Xa level (Anti-Xa)
20.2 Anticoagulants
anti-infective stewardship
7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
anti-infectives
35.1 Urinary Anti-infectives
anti-inflammatory
13.2 Antipsychotics
Anti-inflammatory drugs
39.2 Otic Anti-inflammatories and Anti-infectives
Antianginal drugs
Introduction
Antibiotic drug resistance
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
antibiotics
23.2 Introduction to the Lower Respiratory System,
29.3 Introduction to the Small and Large Intestines
Antibodies
6.1 Introduction to Immunity
Antibody mediated/humoral immunity
6.1 Introduction to Immunity
anticholinergic
22.2 Cardiac Emergency Drugs
Anticholinergic drugs
25.1 Adrenergics and Anticholinergics
anticholinergic effects
30.2 Antidiarrheals
Anticholinergics
11.2 Anti-Parkinsonian Drugs ,
30.1 Antiemetics,
35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Anticoagulant Reversal Agents
20.2 Anticoagulants
Anticoagulants
20.2 Anticoagulants
anticonvulsant drugs
12.1 Epilepsy and Anticonvulsant Drugs
antidepressant
32.4 Other Drugs, Supplements, and Herbal Remedies
antidepressant responses in populations of color
13.1 Antidepressants
antidiabetic
11.2 Anti-Parkinsonian Drugs
Antidiuretic hormone
16.1 Introduction to the Heart, Circulation, and Blood Flow,
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus,
34.1 Introduction to Diuretics
antidysrhythmic drugs
17.2 Class I: Sodium Channel Blockers
Antiestrogens
8.3 Hormonal Therapy
antifungal drugs
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Antigen-antibody interactions
6.1 Introduction to Immunity
Antihistamines
8.2 Chemotherapeutic Drugs,
24.1 Antihistamines and Decongestants,
24.1 Antihistamines and Decongestants,
30.1 Antiemetics,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
antihistamines for ear disorders
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Antihypertensive drugs
Introduction
Antimalarial drugs
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Antimetabolites
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
antiparasitic drugs
7.6 Antiparasitic and Anthelminthic Drugs
antipsychotic
11.2 Anti-Parkinsonian Drugs ,
13.2 Antipsychotics,
13.4 Anxiolytics and Sedative-Hypnotics,
13.5 CNS Stimulants and Nonstimulants
antipyretics
14.2 Nonopioid Analgesics
Antiretroviral Drugs
7.3 Introduction to HIV, AIDS, and Antiretrovirals
antiretroviral therapy (ART)
7.3 Introduction to HIV, AIDS, and Antiretrovirals
antisecretory
31.2 Histamine Blockers and Proton-Pump Inhibitors
antiseizure medications
13.3 Mood Stabilizers
Antithyroid drugs
27.2 Thyroid and Antithyroid Drugs
antitubercular drugs
7.5 Introduction to Tuberculosis and Antitubercular Drugs
Antitussives
24.2 Antitussives
Antivert
30.1 Antiemetics
antiviral drugs
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Anxiolytics
13.4 Anxiolytics and Sedative-Hypnotics
Apixaban
20.2 Anticoagulants
Apokyn
11.2 Anti-Parkinsonian Drugs
Apomorphine hydrochloride
11.2 Anti-Parkinsonian Drugs
apoptosis
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
10.3 Introduction to Alzheimer’s Disease
apothecary system
2.4 Dosage Calculations
Aprepitant
30.1 Antiemetics
aqueous humor
38.1 Introduction to the Eyes
Argatroban
20.2 Anticoagulants
Arimadex
8.3 Hormonal Therapy
Aromasin
8.3 Hormonal Therapy
Aromatase Inhibitors
8.3 Hormonal Therapy
arrhythmias
16.3 Conduction of Electrical Impulses,
17.1 Introduction to Dysrhythmias,
17.1 Introduction to Dysrhythmias
Artane
11.2 Anti-Parkinsonian Drugs
Artificial tears
38.3 Ocular Anesthetics and Lubricants
ascites
34.2 Loop Diuretics
Asian American
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies,
28.1 Introduction to Diabetes
Asian people
15.3 Alcohol Use Disorder Drugs,
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
asociality
13.2 Antipsychotics
Aspirin
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
14.2 Nonopioid Analgesics,
20.3 Antiplatelets,
22.2 Cardiac Emergency Drugs
asthenia
35.1 Urinary Anti-infectives
Astigmatism
38.1 Introduction to the Eyes
Atacand
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Atenolol
17.1 Introduction to Dysrhythmias,
17.3 Class II: Beta Adrenergic Blockers,
18.4 Beta-Adrenergic Blockers
Atezolizumab
8.4 Biologic Response Modifiers
atherosclerosis
21.1 Introduction to Lipoprotein and Apolipoproteins
Ativan
12.1 Epilepsy and Anticonvulsant Drugs ,
13.4 Anxiolytics and Sedative-Hypnotics,
15.3 Alcohol Use Disorder Drugs
Atomoxetine
13.5 CNS Stimulants and Nonstimulants
Atorvastatin
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors,
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors,
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Atralin
40.2 Acne Drugs
atrial fibrillation with rapid ventricular response
17.1 Introduction to Dysrhythmias,
22.2 Cardiac Emergency Drugs
Atrial flutter
17.1 Introduction to Dysrhythmias
Atropine
17.1 Introduction to Dysrhythmias,
17.6 Unclassified Antidysrhythmics,
22.2 Cardiac Emergency Drugs
Attention deficit hyperactivity disorder
13.5 CNS Stimulants and Nonstimulants
atypical antipsychotics
13.2 Antipsychotics
Augmentin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
39.2 Otic Anti-inflammatories and Anti-infectives
autoantibodies
10.1 Introduction to Myasthenia Gravis
autoimmune
11.3 Introduction to Multiple Sclerosis
autoimmune disorders
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
automaticity
16.3 Conduction of Electrical Impulses
Autonomy
3.2 Drug Errors and Prevention
Avanafil
36.7 Phosphodiesterase 5 Inhibitors
avolition
13.2 Antipsychotics
Azathioprine
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Azelaic acid
40.2 Acne Drugs
Azelex
40.2 Acne Drugs
Azilect
11.2 Anti-Parkinsonian Drugs
Azithromycin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
39.2 Otic Anti-inflammatories and Anti-infectives
Azopt
38.4 Antiglaucoma Drugs
B
B lymphocytes
11.3 Introduction to Multiple Sclerosis
Bacterial vaginosis
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
ballismus
11.2 Anti-Parkinsonian Drugs
Baroreceptor reflex
16.1 Introduction to the Heart, Circulation, and Blood Flow
Barotrauma
39.1 Introduction to the Ears
barriers to learning
2.1 Drug Administration and the Nursing Process
basal insulin dosing
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
basal metabolic rate (BMR)
32.1 Introduction to Weight Management
basic formula method
2.4 Dosage Calculations
Beclomethasone
25.2 Corticosteroids
Beclovent
25.2 Corticosteroids
Bempedoic acid
21.1 Introduction to Lipoprotein and Apolipoproteins
Benadryl
8.2 Chemotherapeutic Drugs,
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Beneficence
3.2 Drug Errors and Prevention
benign
Introduction
Benign paroxysmal positional vertigo (BPPV)
39.1 Introduction to the Ears
benign prostatic hyperplasia (BPH)
35.5 Phosphodiesterase 5 Inhibitors
Benzac
40.2 Acne Drugs
Benzathine penicillin G
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
benzodiazepine sedative-hypnotic
13.2 Antipsychotics
Benzodiazepines
12.1 Epilepsy and Anticonvulsant Drugs ,
12.1 Epilepsy and Anticonvulsant Drugs ,
13.4 Anxiolytics and Sedative-Hypnotics,
15.3 Alcohol Use Disorder Drugs
Benzonatate
24.2 Antitussives
benzothiadiazine
28.3 Oral Antidiabetic Drugs
Benzoyl peroxide
40.2 Acne Drugs
Benzphetamine
32.2 Anorexiants
Benztropine mesylate
11.2 Anti-Parkinsonian Drugs
beta blocker
13.5 CNS Stimulants and Nonstimulants,
17.3 Class II: Beta Adrenergic Blockers,
19.3 Beta-Adrenergic Blockers
beta-1 adrenergic agonist
22.2 Cardiac Emergency Drugs
beta-1 receptor agonist
22.3 Shock Drugs
beta-2 adrenergic agonist
25.1 Adrenergics and Anticholinergics
Beta-adrenergic
25.1 Adrenergics and Anticholinergics
beta-adrenergic blockers
2.2 Pharmacokinetics and Pharmacodynamics,
17.1 Introduction to Dysrhythmias,
17.3 Class II: Beta Adrenergic Blockers,
18.4 Beta-Adrenergic Blockers,
19.3 Beta-Adrenergic Blockers,
38.4 Antiglaucoma Drugs
Beta-lactamase inhibitors
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Betamethasone
26.4 Glucocorticoids and Mineralocorticoids
Betapace AF
17.4 Class III: Potassium Channel Blockers
Betaxolol
17.1 Introduction to Dysrhythmias
Betaxolol hydrochloride
38.4 Antiglaucoma Drugs
Bethanechol chloride
35.4 Urinary Stimulants
Betoptic
38.4 Antiglaucoma Drugs
Bevacizumab
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Bicillin L-A
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Bile acid sequestrants
21.1 Introduction to Lipoprotein and Apolipoproteins,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Bimatoprost 0.01% and 0.03% solution
38.4 Antiglaucoma Drugs
Bioavailability
2.2 Pharmacokinetics and Pharmacodynamics
Biologic drugs
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
biologic psoriatic drugs
40.3 Psoriatic Drugs
Biologic Response Modifiers
8.4 Biologic Response Modifiers
Biologic therapy
8.2 Chemotherapeutic Drugs
biologics
1.2 Drug Sources, Forms, and Names,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Biosimilars
1.2 Drug Sources, Forms, and Names
Biphasic COCs
36.2 Hormonal, Contraception, and Infertility Drugs
bipolar disorder
13.1 Antidepressants
Bisacodyl Pr
30.3 Laxatives and Stool Softeners
Bismuth subsalicylate
30.2 Antidiarrheals
Bisoprolol
17.1 Introduction to Dysrhythmias,
17.3 Class II: Beta Adrenergic Blockers,
19.3 Beta-Adrenergic Blockers
Bisphosphonates
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Bivalirudin
20.2 Anticoagulants
Black
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
28.1 Introduction to Diabetes,
28.1 Introduction to Diabetes,
32.1 Introduction to Weight Management,
38.1 Introduction to the Eyes
Black adults
16.1 Introduction to the Heart, Circulation, and Blood Flow,
18.5 Calcium Channel Blockers
Black clients
1.4 Special Considerations,
11.3 Introduction to Multiple Sclerosis,
13.1 Antidepressants,
14.1 Introduction to Pain,
18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors,
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System,
19.6 Adjunct Medications Used in Heart Failure
bladder pain syndrome
35.3 Urinary Analgesics
Blenoxane
8.2 Chemotherapeutic Drugs
Bleomycin
8.2 Chemotherapeutic Drugs
Blood
5.1 Fluid Volume
Blood clotting
4.4 Negative Feedback Loop
blood dyscrasias
35.1 Urinary Anti-infectives
blood fractionation
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Blood products
5.1 Fluid Volume
Bloxiverz
10.2 Cholinergic Drugs
board of nursing (BON)
3.1 Legal Considerations
Body mass index
32.1 Introduction to Weight Management
body surface area
2.4 Dosage Calculations
body surface area (BSA) method
2.4 Dosage Calculations
body weight method
2.4 Dosage Calculations
bone marrow stimulant
13.4 Anxiolytics and Sedative-Hypnotics
Boniva
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Bowman’s capsule
33.1 Introduction to the Renal System
Bowman’s capsule hydrostatic pressure
33.1 Introduction to the Renal System
Bradykinesia
11.1 Introduction to Parkinson’s Disease
brain herniation
12.3 Intracranial Emergencies and Intracranial Emergency Drugs
brand name
1.2 Drug Sources, Forms, and Names
breastfeeding
36.3 Uterine Motility Drugs and Lactation Considerations
Brevibloc
17.3 Class II: Beta Adrenergic Blockers
Brilinta
20.3 Antiplatelets
Brimonidine
38.4 Antiglaucoma Drugs
Brinzolamide 1% solution
38.4 Antiglaucoma Drugs
Brompheniramine
24.1 Antihistamines and Decongestants
bronchodilators
23.2 Introduction to the Lower Respiratory System
Budesonide
25.2 Corticosteroids
Bulk-forming
30.3 Laxatives and Stool Softeners
bundle of His
16.3 Conduction of Electrical Impulses
Buprenex
15.2 Opioid Use Disorder Drugs
Buprenorphine
15.2 Opioid Use Disorder Drugs
Buprenorphine-naltrexone
15.2 Opioid Use Disorder Drugs
Bupropion
15.4 Nicotine Use Disorder Drugs
Bupropion naltrexone
32.4 Other Drugs, Supplements, and Herbal Remedies
Busulfan
8.2 Chemotherapeutic Drugs
Busulfex
8.2 Chemotherapeutic Drugs
C
C (Ascorbic acid)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
calcimimetics
27.1 Introduction to the Thyroid and Parathyroid,
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcipotriene
40.3 Psoriatic Drugs
Calcitonin gene related peptide (CGRP) receptor antagonists
12.2 Migraine Headaches and Migraine Headache Drugs
calcitonin salmon
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
calcitriol
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium (Ca)
5.2 Electrolytes
calcium absorption
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium acetate
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Calcium carbonate
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
31.1 Antacids
Calcium channel blocker
13.4 Anxiolytics and Sedative-Hypnotics,
17.1 Introduction to Dysrhythmias,
17.5 Class IV: Calcium Channel Blockers,
18.5 Calcium Channel Blockers,
22.2 Cardiac Emergency Drugs
Calcium chloride
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
calcium citrate
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
calcium drugs
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium gluconate
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Calcium polycarbophil
30.3 Laxatives and Stool Softeners
Calcium supplements
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Canada’s drug laws
1.2 Drug Sources, Forms, and Names
Canadian Food and Drugs Act
1.2 Drug Sources, Forms, and Names
canaloplasty
38.1 Introduction to the Eyes
Cancidas
39.1 Introduction to the Ears
Candesartan
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Candida auris
39.1 Introduction to the Ears
candidiasis
25.2 Corticosteroids
Cangrelor
20.3 Antiplatelets
Cannabinoids
30.1 Antiemetics
Cannabis (marijuana)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Capecitabine
8.2 Chemotherapeutic Drugs
Caplyta
13.3 Mood Stabilizers
Capto
18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Captopril
18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
carbamide peroxide
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
carbidopa
11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa extended release
11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa immediate-release tablet
11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa oral disintegrating tablet
11.2 Anti-Parkinsonian Drugs
carbohydrates
28.1 Introduction to Diabetes
Carbonic Anhydrase Inhibitors (CAIs)
12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Carboplatin
8.2 Chemotherapeutic Drugs
Cardene
18.5 Calcium Channel Blockers
cardiac cycle
16.2 Pumping Action of the Heart
Cardiac emergencies
Introduction
Cardiac glycosides
19.6 Adjunct Medications Used in Heart Failure
cardiac output
16.1 Introduction to the Heart, Circulation, and Blood Flow,
18.1 Hypertension and Angina,
19.1 Heart Failure,
22.1 Introduction to Cardiac Emergencies and Shock
Cardiogenic shock
22.1 Introduction to Cardiac Emergencies and Shock,
22.1 Introduction to Cardiac Emergencies and Shock,
22.3 Shock Drugs
cardiotoxicity
13.1 Antidepressants
Cardiovascular diseases
Introduction
cardioversion
17.1 Introduction to Dysrhythmias
Cariprazine
13.2 Antipsychotics
Carmustine
8.2 Chemotherapeutic Drugs
Carteolol hydrochloride
38.4 Antiglaucoma Drugs
Cartia XT
17.5 Class IV: Calcium Channel Blockers
Casodex
8.3 Hormonal Therapy
caspofungin
39.1 Introduction to the Ears
Castor oil
30.3 Laxatives and Stool Softeners
Cataplexy
13.5 CNS Stimulants and Nonstimulants
cataracts
38.1 Introduction to the Eyes
catatonia
13.2 Antipsychotics
catecholamine
11.2 Anti-Parkinsonian Drugs
Catecholomethyltransferase (COMT) Inhibitors
11.2 Anti-Parkinsonian Drugs
Cathflo Activase
20.4 Thrombolytics
cations
4.1 What Is Homeostasis?
Celebrex
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
13.1 Antidepressants
cell-cycle nonspecific (CCNS)
8.2 Chemotherapeutic Drugs
cell-cycle specific agents (CCS)
8.2 Chemotherapeutic Drugs
Cell-mediated immunity
6.1 Introduction to Immunity
Center for Drug Evaluation and Research (CDER)
1.2 Drug Sources, Forms, and Names
central nervous system (CNS)
9.2 Structure and Function of the Nervous System
cerebrospinal fluid
12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Certificate of Vaccination
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Cerubidine
8.2 Chemotherapeutic Drugs
Cetirizine hydrochloride
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Cetrorelix acetate
36.2 Hormonal, Contraception, and Infertility Drugs
chalazion
38.1 Introduction to the Eyes
Chantix
15.4 Nicotine Use Disorder Drugs
charting
3.3 Documentation and Informatics
Chemical names
1.2 Drug Sources, Forms, and Names
Chemokine Coreceptor (CCR5) Antagonists
7.3 Introduction to HIV, AIDS, and Antiretrovirals
chemoreceptor trigger zone (CTZ)
30.1 Antiemetics
chemotherapy
8.2 Chemotherapeutic Drugs
chemotherapy administration
8.2 Chemotherapeutic Drugs
children
1.2 Drug Sources, Forms, and Names,
4.1 What Is Homeostasis?,
13.1 Antidepressants,
13.1 Antidepressants,
13.4 Anxiolytics and Sedative-Hypnotics,
14.3 Opioid Agonists and Antagonists,
15.2 Opioid Use Disorder Drugs,
15.4 Nicotine Use Disorder Drugs,
24.1 Antihistamines and Decongestants,
24.1 Antihistamines and Decongestants,
Introduction,
39.1 Introduction to the Ears,
39.1 Introduction to the Ears,
39.2 Otic Anti-inflammatories and Anti-infectives
children and adolescents
13.2 Antipsychotics,
18.1 Hypertension and Angina,
32.1 Introduction to Weight Management
Chlor-Trimeton
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Chlorambucil
8.2 Chemotherapeutic Drugs
Chloride (Cl)
5.2 Electrolytes
Chlorpheniramine
24.1 Antihistamines and Decongestants
Chlorpheniramine maleate
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
chlorpropamide
13.2 Antipsychotics
cholelithiasis
32.1 Introduction to Weight Management
Cholesevelam
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
cholesterol absorption inhibitors
21.4 Cholesterol Absorption Inhibitors
cholesterol management
21.1 Introduction to Lipoprotein and Apolipoproteins
Cholestyramine
21.3 Bile Acid Sequestrants, Fibrates, and Niacin,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Cholinergic agonists
10.2 Cholinergic Drugs
cholinergic blockers
11.2 Anti-Parkinsonian Drugs
cholinergic nerves
9.3 Characteristics of Drugs to Treat Nervous System Disorders
cholinergic receptors
Introduction
choreoathetosis
11.2 Anti-Parkinsonian Drugs
Chromium picolinate
32.1 Introduction to Weight Management,
32.4 Other Drugs, Supplements, and Herbal Remedies
Chronic bronchitis
23.2 Introduction to the Lower Respiratory System
Chronic obstructive pulmonary disease (COPD)
23.2 Introduction to the Lower Respiratory System,
Introduction
Chronic pain
14.1 Introduction to Pain
chronotropic
10.4 Alzheimer’s Drugs
Chvostek sign
27.1 Introduction to the Thyroid and Parathyroid
Chylomicrons
21.1 Introduction to Lipoprotein and Apolipoproteins
Cinacalcet
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Cinvanti
30.1 Antiemetics
Ciprofloxacin 0.2%
and hydrocortisone 1% 39.2 Otic Anti-inflammatories and Anti-infectives
and hydrocortisone 1% 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin 0.3%
and dexamethasone 0.1% 39.2 Otic Anti-inflammatories and Anti-infectives
and dexamethasone 0.1% 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin
hydrochloride 0.3% 38.2 Ocular Anti-inflammatories and Anti-infectives
hydrochloride 0.3% 38.2 Ocular Anti-inflammatories and Anti-infectives
circadian rhythm
32.1 Introduction to Weight Management
Cisplatin
8.2 Chemotherapeutic Drugs
Citalopram
13.1 Antidepressants
Citrucil
30.3 Laxatives and Stool Softeners
Claritin
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Class I: Sodium channel blockers
17.1 Introduction to Dysrhythmias
class Ia antiarrhythmic
22.2 Cardiac Emergency Drugs
Class II: Beta-adrenergic blockers
17.1 Introduction to Dysrhythmias
class III antiarrhythmic
22.2 Cardiac Emergency Drugs
Class III: Potassium channel blockers
17.1 Introduction to Dysrhythmias
class IV antiarrhythmic
22.2 Cardiac Emergency Drugs
Class IV: Calcium channel blocker
17.1 Introduction to Dysrhythmias
class V antidysrhythmic
22.2 Cardiac Emergency Drugs
Clean eating
32.1 Introduction to Weight Management
Cleocin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them,
40.2 Acne Drugs
client education
2.1 Drug Administration and the Nursing Process
clients with darker skin
40.1 Introduction to the Skin and Its Function
Clindamycin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them,
40.2 Acne Drugs
Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
15.3 Alcohol Use Disorder Drugs
Clinical judgment
2.1 Drug Administration and the Nursing Process
ClobaDerm
40.3 Psoriatic Drugs
Clobetasol
40.3 Psoriatic Drugs
Clonazepam
12.1 Epilepsy and Anticonvulsant Drugs ,
13.4 Anxiolytics and Sedative-Hypnotics,
13.4 Anxiolytics and Sedative-Hypnotics,
13.4 Anxiolytics and Sedative-Hypnotics
Clopidogrel
20.3 Antiplatelets
Clorazepate
12.1 Epilepsy and Anticonvulsant Drugs
Closed-angle glaucoma
38.1 Introduction to the Eyes
clotting factors
20.1 Introduction to Clotting and Coagulation
CNS stimulants
13.5 CNS Stimulants and Nonstimulants
coagulation cascade
20.1 Introduction to Clotting and Coagulation
Coal tar lotion
40.3 Psoriatic Drugs
Coal tar shampoo
40.3 Psoriatic Drugs
cochlear nerve
39.1 Introduction to the Ears
Cogentin
11.2 Anti-Parkinsonian Drugs
cognitive behavioral therapy
13.5 CNS Stimulants and Nonstimulants,
15.1 Introduction to Substance Use Disorders
cognitive domain
2.1 Drug Administration and the Nursing Process
Colazal
13.2 Antipsychotics
Colchicine
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Colestipol
21.3 Bile Acid Sequestrants, Fibrates, and Niacin,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
collaborative practice
1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
colloidal oncotic pressure
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Colony Stimulating Factors
8.2 Chemotherapeutic Drugs
Combigan
38.4 Antiglaucoma Drugs
Combined oral contraceptives (COCs)
36.2 Hormonal, Contraception, and Infertility Drugs
Comorbidity Tests
28.1 Introduction to Diabetes
Compazine
30.1 Antiemetics
complementary and alternative medicine (CAM)
1.2 Drug Sources, Forms, and Names
Complementary and alternative therapies
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
complete blood count (CBC)
Introduction
complex focal seizures
12.1 Epilepsy and Anticonvulsant Drugs
Compro
30.1 Antiemetics
Computed tomography (CT) scan
12.1 Epilepsy and Anticonvulsant Drugs
computerized prescriber order entry (CPOE)
3.3 Documentation and Informatics
COMT inhibitors
11.2 Anti-Parkinsonian Drugs
Comtan
11.2 Anti-Parkinsonian Drugs
Conduction
14.1 Introduction to Pain
confidentiality
3.1 Legal Considerations
Conjugate vaccines
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Conjugated estrogens
37.2 Feminizing Hormonal Therapy
Conjugated linoleic acid (CLA)
32.4 Other Drugs, Supplements, and Herbal Remedies
Conjunctival hyperemia
38.4 Antiglaucoma Drugs
constipation
14.3 Opioid Agonists and Antagonists
continuous glucose monitor (CGM)
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Contraceptives
36.2 Hormonal, Contraception, and Infertility Drugs
controlled substances
14.3 Opioid Agonists and Antagonists
Controlled Substances Act
1.3 Drug Classifications and Prototypes
convulsions
12.1 Epilepsy and Anticonvulsant Drugs
Corgard
18.4 Beta-Adrenergic Blockers
coronary artery disease
21.1 Introduction to Lipoprotein and Apolipoproteins
Corphedra
25.1 Adrenergics and Anticholinergics
Correctol
30.3 Laxatives and Stool Softeners
cortical nephrons
33.1 Introduction to the Renal System
corticosteroids
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
8.2 Chemotherapeutic Drugs,
25.2 Corticosteroids
Cortisone acetate
26.4 Glucocorticoids and Mineralocorticoids
Cortisporin
26.4 Glucocorticoids and Mineralocorticoids,
39.2 Otic Anti-inflammatories and Anti-infectives
Cosmegen
8.2 Chemotherapeutic Drugs
Coumadin
20.2 Anticoagulants
Counterfeit drugs
1.2 Drug Sources, Forms, and Names
COVID-19 vaccine, mRNA
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Cozaar
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Creon
30.2 Antidiarrheals
cromolyn sodium
25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Cryoprecipitated anti-hemophilic factor (cryo)
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Crystalloid solutions
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
cultural considerations
1.4 Special Considerations
Cushing’s syndrome
26.4 Glucocorticoids and Mineralocorticoids
customary system
2.4 Dosage Calculations
Cutaneous Administration
2.3 Drug Administration Routes, Preparation, and Administration
Cutar
40.3 Psoriatic Drugs
cutting off
2.4 Dosage Calculations
cyclooxygenase
14.1 Introduction to Pain
Cyclophosphamide
8.2 Chemotherapeutic Drugs
cyclosporine
38.2 Ocular Anti-inflammatories and Anti-infectives
Cymbalta
13.1 Antidepressants
cystic fibrosis
24.3 Expectorants and Mucolytics
Cytarabine
8.2 Chemotherapeutic Drugs
cytochrome P-450 (CYP) deficiencies
32.1 Introduction to Weight Management
Cytochrome P-450 Inhibitors
7.3 Introduction to HIV, AIDS, and Antiretrovirals
cytochrome P450 2D6
14.3 Opioid Agonists and Antagonists
cytochrome P450 enzyme system
13.1 Antidepressants
Cytokines
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
14.1 Introduction to Pain
cytoplasm
4.1 What Is Homeostasis?
Cytoxan
8.2 Chemotherapeutic Drugs
D
D2 (Ergocalciferol)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
D3 (Cholecalciferol)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Dabigatran
20.2 Anticoagulants
dacryoadenitis
38.1 Introduction to the Eyes
dacryocystitis
38.1 Introduction to the Eyes
Dactinomycin
8.2 Chemotherapeutic Drugs
Dalteparin
20.2 Anticoagulants
Dantrolene sodium
11.4 Drugs Used in the Treatment of Multiple Sclerosis
Dapagliflozin
19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is),
28.3 Oral Antidiabetic Drugs
Daridorexant
13.4 Anxiolytics and Sedative-Hypnotics
Daunorubicin
8.2 Chemotherapeutic Drugs
Decadron
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
8.2 Chemotherapeutic Drugs,
26.4 Glucocorticoids and Mineralocorticoids
Declomycin
26.3 Antidiuretic Hormones
decongestant
24.1 Antihistamines and Decongestants,
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
deep vein thrombosis (DVT)
20.1 Introduction to Clotting and Coagulation
defibrillation
22.1 Introduction to Cardiac Emergencies and Shock
Delatestryl
37.3 Masculinizing Hormonal Therapy
Delayed puberty
36.6 Androgens, Antiandrogens, and Anabolic Steroids
delirium tremens
15.3 Alcohol Use Disorder Drugs
delusions
10.3 Introduction to Alzheimer’s Disease
Demeclocycline
26.3 Antidiuretic Hormones
demyelination
11.3 Introduction to Multiple Sclerosis
Depakote
13.3 Mood Stabilizers
Depakote ER
13.3 Mood Stabilizers
Depo-Provera
36.2 Hormonal, Contraception, and Infertility Drugs,
36.2 Hormonal, Contraception, and Infertility Drugs
Depo-testosterone
36.6 Androgens, Antiandrogens, and Anabolic Steroids,
37.3 Masculinizing Hormonal Therapy
depolarization
16.3 Conduction of Electrical Impulses
depot injections
13.2 Antipsychotics
Depression
13.1 Antidepressants
Dermovate
40.3 Psoriatic Drugs
Desiccated thyroid extract
27.2 Thyroid and Antithyroid Drugs
Desloratadine
24.1 Antihistamines and Decongestants
Desmopressin
26.3 Antidiuretic Hormones
Desogestrel/ethinyl estradiol
36.2 Hormonal, Contraception, and Infertility Drugs,
36.2 Hormonal, Contraception, and Infertility Drugs
Dexamethasone
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
8.2 Chemotherapeutic Drugs,
26.4 Glucocorticoids and Mineralocorticoids
Dexamethasone sodium phosphate
38.2 Ocular Anti-inflammatories and Anti-infectives
Dexmethylphenidate
13.5 CNS Stimulants and Nonstimulants
Dextroamphetamine
13.5 CNS Stimulants and Nonstimulants
Dextromethorphan
24.2 Antitussives
Diabetes
Introduction
diabetes insipidus
26.3 Antidiuretic Hormones
Diagnostic testing
27.1 Introduction to the Thyroid and Parathyroid
diastole
16.2 Pumping Action of the Heart
diastolic blood pressure
18.1 Hypertension and Angina
Diazepam
12.1 Epilepsy and Anticonvulsant Drugs ,
13.4 Anxiolytics and Sedative-Hypnotics,
13.4 Anxiolytics and Sedative-Hypnotics
Diazoxide
28.3 Oral Antidiabetic Drugs
Diclofenac sodium
38.2 Ocular Anti-inflammatories and Anti-infectives
Dietary Supplement and Health Education Act (DSHEA)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Differin
40.2 Acne Drugs
Diffusion
23.3 Oxygenation and Gas Exchange
Digoxin
17.1 Introduction to Dysrhythmias,
17.6 Unclassified Antidysrhythmics,
19.6 Adjunct Medications Used in Heart Failure
dihydroxy-vitamin D3
27.1 Introduction to the Thyroid and Parathyroid
Dilaudid
14.3 Opioid Agonists and Antagonists
diltiazem
13.4 Anxiolytics and Sedative-Hypnotics,
17.1 Introduction to Dysrhythmias,
17.5 Class IV: Calcium Channel Blockers,
18.5 Calcium Channel Blockers,
22.2 Cardiac Emergency Drugs
Dimensional analysis
2.4 Dosage Calculations
Diovan
18.3 Angiotensin II Receptor Blockers (ARBs),
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Diphenhydramine
8.2 Chemotherapeutic Drugs,
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Diphenoxylate with atropine
30.2 Antidiarrheals
Diphtheria, tetanus toxoid, and acellular pertussis vaccine
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
direct observed therapy
15.2 Opioid Use Disorder Drugs
Direct-acting cholinergic agonists
10.2 Cholinergic Drugs
Direct-acting oral anticoagulants (DOACs)
20.2 Anticoagulants
Disease-modifying antirheumatic drugs (DMARDs)
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Disopyramide
17.1 Introduction to Dysrhythmias
distribution
2.2 Pharmacokinetics and Pharmacodynamics
Distributive shock
22.1 Introduction to Cardiac Emergencies and Shock
Disulfiram
15.3 Alcohol Use Disorder Drugs
Diuretic braking
34.1 Introduction to Diuretics
diuretic drugs
5.1 Fluid Volume
Diuretic resistance
34.1 Introduction to Diuretics
Diuretic therapy
Introduction
DOAC Reversal Agents
20.2 Anticoagulants
Dobutamine
22.2 Cardiac Emergency Drugs
Docetaxel
8.2 Chemotherapeutic Drugs
documentation
3.3 Documentation and Informatics
Docusate calcium
30.3 Laxatives and Stool Softeners
Docusate sodium
30.3 Laxatives and Stool Softeners
Dolutegravir/rilpivirine
7.3 Introduction to HIV, AIDS, and Antiretrovirals
Donepezil
10.4 Alzheimer’s Drugs
Donepezil transdermal
10.4 Alzheimer’s Drugs
Dopamine
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
22.2 Cardiac Emergency Drugs
Dopamine antagonists
11.2 Anti-Parkinsonian Drugs
Dornase alfa
24.3 Expectorants and Mucolytics
Dorzolamide 2% solution
38.4 Antiglaucoma Drugs
Dosage calculations
2.4 Dosage Calculations
downregulated
15.3 Alcohol Use Disorder Drugs
Doxorubicin
8.2 Chemotherapeutic Drugs
Doxycin
40.2 Acne Drugs
Doxycycline
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Doxycycline hyclate
40.2 Acne Drugs
Dronabinol
30.1 Antiemetics
Drospirenone/ethinyl estradiol
36.2 Hormonal, Contraception, and Infertility Drugs
drug administration
Introduction
drug calculation
2.4 Dosage Calculations
Drug Enforcement Administration (DEA)
1.2 Drug Sources, Forms, and Names,
15.2 Opioid Use Disorder Drugs
drug formulary
1.4 Special Considerations
drug label
2.4 Dosage Calculations
drug prototype
1.3 Drug Classifications and Prototypes
Drug Supply Chain Security Act
1.2 Drug Sources, Forms, and Names
Drug tolerance
12.1 Epilepsy and Anticonvulsant Drugs
Dry macular degeneration (DMD)
38.1 Introduction to the Eyes
Dulcolax
30.3 Laxatives and Stool Softeners
Duloxetine
13.1 Antidepressants
Duragesic
14.3 Opioid Agonists and Antagonists
Duramorph
14.3 Opioid Agonists and Antagonists
duration of action
2.2 Pharmacokinetics and Pharmacodynamics
Durvalumab
8.4 Biologic Response Modifiers
Duvoid
35.4 Urinary Stimulants
dyskinesias
11.2 Anti-Parkinsonian Drugs
Dyslipidemia
21.1 Introduction to Lipoprotein and Apolipoproteins
dysmenorrhea
31.3 Pepsin Inhibitors and Prostaglandin Analogues
E
E (Alpha-tocopherol)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
ear
Introduction
eardrum
39.1 Introduction to the Ears
East Asian
32.1 Introduction to Weight Management
eating disorder
32.2 Anorexiants
Echinocandins
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
39.1 Introduction to the Ears
echothiopate
10.2 Cholinergic Drugs
Edoxaban
20.2 Anticoagulants
effector
4.1 What Is Homeostasis?
Effexor
13.1 Antidepressants
Effient
20.3 Antiplatelets
ejection fraction
19.1 Heart Failure
Eldepryl
11.2 Anti-Parkinsonian Drugs
Electrocardiography (EKG or ECG)
16.3 Conduction of Electrical Impulses
Electroencephalogram (EEG)
12.1 Epilepsy and Anticonvulsant Drugs
electrolyte balance
4.1 What Is Homeostasis?
Electrolytes
5.2 Electrolytes
electronic medication administration record
3.3 Documentation and Informatics
Eliquis
20.2 Anticoagulants
Ellence
8.2 Chemotherapeutic Drugs
Eloxatin
8.2 Chemotherapeutic Drugs
Emend
30.1 Antiemetics
Empagliflozin
19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is),
28.3 Oral Antidiabetic Drugs
Emsam
13.1 Antidepressants
Emulsoil
30.3 Laxatives and Stool Softeners
Enalapril
18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors,
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Enbrel
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
40.3 Psoriatic Drugs
end-stage renal disease (ESRD)
34.1 Introduction to Diuretics
Endocrine glands
Introduction
endocrine system
Introduction
Enteral administration
1.2 Drug Sources, Forms, and Names,
2.3 Drug Administration Routes, Preparation, and Administration
Ephedrine
25.1 Adrenergics and Anticholinergics
epinephrine
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
22.2 Cardiac Emergency Drugs,
22.3 Shock Drugs,
25.1 Adrenergics and Anticholinergics,
25.1 Adrenergics and Anticholinergics
Epirubicin
8.2 Chemotherapeutic Drugs
Episcleritis
38.1 Introduction to the Eyes
Eplerenone
19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System,
34.4 Potassium-Sparing Diuretics
Epoetin alfa
8.2 Chemotherapeutic Drugs
Epogen
8.2 Chemotherapeutic Drugs
Eptifibatide
20.3 Antiplatelets
Ergocalciferol
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Ergot alkaloids
12.2 Migraine Headaches and Migraine Headache Drugs
ergot derivatives
11.2 Anti-Parkinsonian Drugs
Erlotinib
8.4 Biologic Response Modifiers
erythema multiforme
35.1 Urinary Anti-infectives
Erythrocytopenia
8.2 Chemotherapeutic Drugs
Erythromycin 0.5%
38.2 Ocular Anti-inflammatories and Anti-infectives
Erythropoietin production
33.1 Introduction to the Renal System
Escitalopram
13.1 Antidepressants
Esomeprazole
31.2 Histamine Blockers and Proton-Pump Inhibitors
Essential fatty acids (EFAs)
32.1 Introduction to Weight Management
Estraderm Transdermal
36.2 Hormonal, Contraception, and Infertility Drugs
estradiol
36.2 Hormonal, Contraception, and Infertility Drugs,
36.2 Hormonal, Contraception, and Infertility Drugs
Estradiol cypionate
37.2 Feminizing Hormonal Therapy
Estradiol levonorgestrel
36.2 Hormonal, Contraception, and Infertility Drugs
Estradiol patch
37.2 Feminizing Hormonal Therapy
Estradiol valerate
37.2 Feminizing Hormonal Therapy
estrogen
36.1 Review of the Female Reproductive System ,
36.2 Hormonal, Contraception, and Infertility Drugs
Estrogen Derivatives
36.2 Hormonal, Contraception, and Infertility Drugs
Estrogen receptor modulators (ERMs)
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
estrogen therapy
36.2 Hormonal, Contraception, and Infertility Drugs
Eszopiclone
13.4 Anxiolytics and Sedative-Hypnotics
Etanercept
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
40.3 Psoriatic Drugs
ethanol
15.3 Alcohol Use Disorder Drugs
Ethical care
3.2 Drug Errors and Prevention
Ethinyl estradiol desogestrel
36.2 Hormonal, Contraception, and Infertility Drugs
Ethosuximide (Zarontin)
12.1 Epilepsy and Anticonvulsant Drugs
Etoposide
8.2 Chemotherapeutic Drugs
Etrivex
40.3 Psoriatic Drugs
Eulexin
8.3 Hormonal Therapy
Eustachian tube
39.1 Introduction to the Ears
Evolocumab
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors,
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
exacerbations
11.3 Introduction to Multiple Sclerosis
Exelon
10.4 Alzheimer’s Drugs
Exemestane
8.3 Hormonal Therapy
exfoliative dermatitis
35.1 Urinary Anti-infectives
Exorex
40.3 Psoriatic Drugs
Expectorants
24.3 Expectorants and Mucolytics
external auditory canal
39.1 Introduction to the Ears
External ocular structures
38.1 Introduction to the Eyes
extravasate
8.2 Chemotherapeutic Drugs
eye
Introduction
F
Factor V Leiden
20.1 Introduction to Clotting and Coagulation
Familial hypercholesterolemia
21.1 Introduction to Lipoprotein and Apolipoproteins
Faslodex
8.3 Hormonal Therapy
fasting blood glucose
28.1 Introduction to Diabetes
Fat-soluble vitamins
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Febrile neutropenia
8.2 Chemotherapeutic Drugs
feedback loop
4.1 What Is Homeostasis?
female reproductive system
36.1 Review of the Female Reproductive System
female-to-male (FTM) transition
37.3 Masculinizing Hormonal Therapy
fenestrated capillaries
33.1 Introduction to the Renal System
Fenofibrate
21.3 Bile Acid Sequestrants, Fibrates, and Niacin,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Fenofibric acid
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Fentanyl
14.3 Opioid Agonists and Antagonists
Fetzima
13.1 Antidepressants
Fexofenadine
24.1 Antihistamines and Decongestants
Fiberall
30.3 Laxatives and Stool Softeners
FiberCon
30.3 Laxatives and Stool Softeners
Fibrates
21.1 Introduction to Lipoprotein and Apolipoproteins,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
fibrinogen
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products,
20.1 Introduction to Clotting and Coagulation
fibrinolysis
20.1 Introduction to Clotting and Coagulation
fibrosis
8.2 Chemotherapeutic Drugs
Filgrastim
8.2 Chemotherapeutic Drugs
Finacea
40.2 Acne Drugs
Finevin
40.2 Acne Drugs
first-day start method
36.2 Hormonal, Contraception, and Infertility Drugs
first-generation antihistamines
24.1 Antihistamines and Decongestants,
39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
First-generation short-acting sulfonylureas
28.3 Oral Antidiabetic Drugs
first-pass effect
2.2 Pharmacokinetics and Pharmacodynamics
Flagyl
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them,
7.6 Antiparasitic and Anthelminthic Drugs,
40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Flavoxate hydrochloride
35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics,
35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Flovent HFA
25.2 Corticosteroids
Fludara
8.2 Chemotherapeutic Drugs
Fludarabine
8.2 Chemotherapeutic Drugs
fluid balance
4.1 What Is Homeostasis?
fluid imbalance
5.1 Fluid Volume
Fluid volume
5.1 Fluid Volume
Fluid volume deficit
5.1 Fluid Volume
Fluid volume excess
5.1 Fluid Volume
fluid volume overload
34.5 Thiazide and Thiazide-Like Diuretics
Fluid volume replacement
5.1 Fluid Volume
fluoroquinolones
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Fluoxymesterone
36.6 Androgens, Antiandrogens, and Anabolic Steroids
Fluphenazine
13.2 Antipsychotics
Flutamide
8.3 Hormonal Therapy
Fluticasone
25.2 Corticosteroids
Fluvastatin
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors,
21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
focal seizures
12.1 Epilepsy and Anticonvulsant Drugs
Folate Antimetabolites
8.2 Chemotherapeutic Drugs
Follicle-stimulating hormone (FSH)
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus,
36.1 Review of the Female Reproductive System
Follistim AQ
36.2 Hormonal, Contraception, and Infertility Drugs
Food and Drug Administration (FDA)
1.2 Drug Sources, Forms, and Names
food desert
32.1 Introduction to Weight Management
foramen of Monro
12.3 Intracranial Emergencies and Intracranial Emergency Drugs
forms of medication
2.3 Drug Administration Routes, Preparation, and Administration
Fosamax
27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones,
36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Fragmin
20.2 Anticoagulants
full mu opioid receptor agonist
15.2 Opioid Use Disorder Drugs
fulminant hepatic necrosis
12.3 Intracranial Emergencies and Intracranial Emergency Drugs,
35.1 Urinary Anti-infectives
Fulvestrant
8.3 Hormonal Therapy
Fungal infections
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Furadantin
35.1 Urinary Anti-infectives
Fusion Pump Inhibitors
7.3 Introduction to HIV, AIDS, and Antiretrovirals
G
GABA structural analogs
11.4 Drugs Used in the Treatment of Multiple Sclerosis
Gabapentin
11.4 Drugs Used in the Treatment of Multiple Sclerosis,
12.1 Epilepsy and Anticonvulsant Drugs
Galantamine
10.4 Alzheimer’s Drugs
Gamma-aminobutyric acid (GABA)
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
12.1 Epilepsy and Anticonvulsant Drugs
Gamma-Aminobutyric Acid Structural Analogs
11.4 Drugs Used in the Treatment of Multiple Sclerosis
Garamycin
7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs,
38.2 Ocular Anti-inflammatories and Anti-infectives
Gas exchange
23.3 Oxygenation and Gas Exchange
gastrointestinal (GI) system
Introduction
Gemfibrozil
21.3 Bile Acid Sequestrants, Fibrates, and Niacin,
21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Gemzar
8.2 Chemotherapeutic Drugs
gender and racial bias
18.1 Hypertension and Angina
Gender dysphoria
37.1 Overview of Transgender and Nonbinary Health
Gender expression
37.1 Overview of Transgender and Nonbinary Health
Gender fluid
37.1 Overview of Transgender and Nonbinary Health
Gender identity
37.1 Overview of Transgender and Nonbinary Health
gender nonconforming
37.1 Overview of Transgender and Nonbinary Health
gender-related topics
37.1 Overview of Transgender and Nonbinary Health
generalized seizures
12.1 Epilepsy and Anticonvulsant Drugs
Generic names
1.2 Drug Sources, Forms, and Names
Gentamicin sulfate 0.3%
38.2 Ocular Anti-inflammatories and Anti-infectives
Geodon
13.2 Antipsychotics
geographic regions
11.1 Introduction to Parkinson’s Disease
gestational diabetes
28.1 Introduction to Diabetes
gingival hyperplasia
12.1 Epilepsy and Anticonvulsant Drugs
Glatiramer acetate
11.4 Drugs Used in the Treatment of Multiple Sclerosis
Glaucoma
38.1 Introduction to the Eyes
Glimepiride
28.3 Oral Antidiabetic Drugs
glitazones
28.3 Oral Antidiabetic Drugs
Glomerular capillary hydrostatic pressure
33.1 Introduction to the Renal System
Glomerular capillary oncotic pressure
33.1 Introduction to the Renal System
Glomerular filtration
33.1 Introduction to the Renal System
glomerular filtration rate
33.1 Introduction to the Renal System,
33.2 Renal-Associated Fluid Volume Excess,
34.1 Introduction to Diuretics
Glomerulopathies
33.1 Introduction to the Renal System
glomerulus
33.1 Introduction to the Renal System
GLP-1 receptor agonists
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Glucagon
28.1 Introduction to Diabetes,
28.3 Oral Antidiabetic Drugs,
32.1 Introduction to Weight Management
Glucagon-Like Peptide-1
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs,
32.4 Other Drugs, Supplements, and Herbal Remedies
Glucocorticoids
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus,
26.4 Glucocorticoids and Mineralocorticoids
Gluconeogenesis
33.1 Introduction to the Renal System
Glucophage
28.3 Oral Antidiabetic Drugs
Glucophage XR
28.3 Oral Antidiabetic Drugs
glucose
5.2 Electrolytes
glucose tablets
28.1 Introduction to Diabetes
Glucotrol
28.3 Oral Antidiabetic Drugs
Glucotrol XL
28.3 Oral Antidiabetic Drugs
Glucovance
28.3 Oral Antidiabetic Drugs
Glyburide
28.3 Oral Antidiabetic Drugs
Glyburide/metformin
28.3 Oral Antidiabetic Drugs
glycemic index (GI)
32.1 Introduction to Weight Management
glycolysis
5.2 Electrolytes
glycosylated hemoglobin (A1c)
28.1 Introduction to Diabetes
Glyset
28.3 Oral Antidiabetic Drugs
Gocovri
11.2 Anti-Parkinsonian Drugs
gonadotropin-releasing hormone (GnRH)
36.1 Review of the Female Reproductive System
Good Manufacturing Practices (GMPs)
5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
grades of hypertension
18.1 Hypertension and Angina
grand mal seizures
12.1 Epilepsy and Anticonvulsant Drugs
Granisetron
30.1 Antiemetics
granulocytes
8.2 Chemotherapeutic Drugs
granulocytopenia
8.2 Chemotherapeutic Drugs
Graves’ disease
27.1 Introduction to the Thyroid and Parathyroid
Green Tea Extract
32.4 Other Drugs, Supplements, and Herbal Remedies
Growth hormone (GH)
26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
growth hormone receptor antagonists
26.2 Growth Hormones and Suppressants
growth hormone suppressants
26.2 Growth Hormones and Suppressants
Guaifenesin
24.3 Expectorants and Mucolytics
Guanfacine
13.5 CNS Stimulants and Nonstimulants
H
H1 receptors
24.1 Antihistamines and Decongestants
hallucinations
10.3 Introduction to Alzheimer’s Disease
hard-stop alert
3.3 Documentation and Informatics
Hashimoto thyroiditis
27.1 Introduction to the Thyroid and Parathyroid
HCTZ
19.5 Diuretics
HDL-cholesterol
21.1 Introduction to Lipoprotein and Apolipoproteins
Health Information Technology for Economic and Clinical Health (HITECH) Act
3.1 Legal Considerations
Health Insurance Portability and Accountability Act
3.1 Legal Considerations
Health literacy
2.1 Drug Administration and the Nursing Process
Healthy People 2030
Introduction
Heart failure
19.1 Heart Failure
heart failure with preserved ejection fraction (HFpEF)
19.1 Heart Failure
heart failure with reduced ejection fraction (HFrEF)
19.1 Heart Failure
Hematologic cancers
8.1 Introduction to Cancer and Phases of Cancer Therapy
hemoglobin
Introduction
Hemolytic reactions
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
hemorrhagic cystitis
8.2 Chemotherapeutic Drugs
Heparin-induced thrombocytopenia (HIT)
20.2 Anticoagulants
Hepatitis A vaccine
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Hepatitis B vaccine
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
hepatotoxicity
14.2 Nonopioid Analgesics
Herpes simplex virus (HSV)
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
High-density lipoproteins (HDL or HDL-cholesterol)
21.1 Introduction to Lipoprotein and Apolipoproteins
Hiprex
35.1 Urinary Anti-infectives
Hispanic
11.3 Introduction to Multiple Sclerosis,
28.1 Introduction to Diabetes,
28.1 Introduction to Diabetes,
32.1 Introduction to Weight Management,
38.1 Introduction to the Eyes
Histamine
9.3 Characteristics of Drugs to Treat Nervous System Disorders,
23.1 Introduction to the Upper Respiratory System,
24.1 Antihistamines and Decongestants,
25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Histamine Blockers
31.2 Histamine Blockers and Proton-Pump Inhibitors
Histamine type-2 receptor antagonists
29.3 Introduction to the Small and Large Intestines
histamine-1 receptor antagonist
13.2 Antipsychotics
HIV transmission
7.3 Introduction to HIV, AIDS, and Antiretrovirals
HMG CoA reductase
21.1 Introduction to Lipoprotein and Apolipoproteins
Homeostasis
4.1 What Is Homeostasis?,
4.3 Maintaining Homeostasis,
4.4 Negative Feedback Loop,
9.1 Introduction to the Nervous System,
Introduction
homeostatic mechanism
4.3 Maintaining Homeostasis
homeostatic response system
4.4 Negative Feedback Loop
Hoodia gordonii
32.4 Other Drugs, Supplements, and Herbal Remedies
hordeolum
38.1 Introduction to the Eyes
hormonal therapy
8.3 Hormonal Therapy
hormone replacement therapy
36.2 Hormonal, Contraception, and Infertility Drugs,
36.2 Hormonal, Contraception, and Infertility Drugs
household system
2.4 Dosage Calculations
Human chorionic gonadotropin (hCG)
36.2 Hormonal, Contraception, and Infertility Drugs
human immunodeficiency virus
7.3 Introduction to HIV, AIDS, and Antiretrovirals
Human papillomavirus
6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations,
7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Human regular insulin
28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Humira
6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs,
40.3 Psoriatic Drugs
Hydantoins
12.1 Epilepsy and Anticonvulsant Drugs
Hydralazine and isosorbide dinitrate
19.6 Adjunct Medications Used in Heart Failure
hydrochloric (HCl) acid
29.1 Introduction to the Gastrointestinal System and Oral Cavity,
29.2 Introduction to the Esophagus and Stomach,
Introduction
hydrochloride
14.3 Opioid Agonists and Antagonists
Hydrocortisone
26.4 Glucocorticoids and Mineralocorticoids,
40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Hydrodiuril
34.5 Thiazide and Thiazide-Like Diuretics
Hydromorphone
14.3 Opioid Agonists and Antagonists
hydrostatic pressure
4.3 Maintaining Homeostasis
Hydroxychloroquine
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs,
6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
hydroxyethyl starch (HES) products
5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Hydroxyzine
30.1 Antiemetics
Hyperacidity
Introduction
Hyperchloremia
5.2 Electrolytes
hypercholesterolemia
21.1 Introduction to Lipoprotein and Apolipoproteins
hypercoagulable
20.1 Introduction to Clotting and Coagulation
Hyperglycemia
28.1 Introduction to Diabetes